手術後の吐き気と嘔吐の世界市場レポート 2025年

手術後の吐き気と嘔吐市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0%で29億7,000万米ドルに成長します。予測期間中に予測される成長は、医薬品需要の増加、併用療法の台頭、意識の高まりとヘルスケア投資、老人人口の増加、がん患者数の増加に起因しています。この期間に予想される主な動向には、制吐療法の進歩、戦略的提携、革新的な薬剤処方、高度診断ツールの統合、電子シミュレーション機器の開発などがあります。

外科手術の増加は手術後の吐き気と嘔吐市場の成長を促進すると予想されます。外科的処置は、損傷した組織、臓器、または異常を診断、治療、または切断や操作によって除去するためのツールを利用する医療介入を含みます。外科手術の増加は、医療技術の進歩によるもので、手術の安全性、有効性、低侵襲性が向上し、患者に受け入れられ、適用範囲が広がっています。手術後の吐き気と嘔吐の効果的な管理は、患者の快適性の向上、回復時間の短縮、合併症の最小化、術後ケアの円滑化によって外科手術を強化し、最終的に手術成績の向上につながります。例えば、2024年11月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、2023-24年の間に、公立病院の選択手術待ちリストから手術のために入院した患者は77万1,600人で、2022-23年と比較して4.9％増加したと報告しました。この動向は、手術件数の増加を浮き彫りにしており、手術後の吐き気と嘔吐市場の拡大に拍車をかけています。

手術後の吐き気と嘔吐市場の各社は、先進的な乳剤製剤と徐放性技術を用いた重要な注射薬の開発に注力し、治療効果を向上させ、外科手術患者の症状を長時間緩和しています。このような重要な注射薬は、注射によって投与され、重篤または緊急な病状に即効的かつ効果的な治療を提供するために不可欠な薬剤です。例えば、2024年7月、米国の専門製薬会社であるアベナシー社は、0.25mg/5mL単回投与バイアル入りのパロノセトロン塩酸塩注射液を発売しました。この製剤は、ヘルスケアプロバイダーが投与ミスを減らし、患者の安全性を向上させるのに役立ちます。この注射剤は、化学療法による悪心・嘔吐の予防や、手術後24時間までの手術後の吐き気と嘔吐管理に使用され、これらの症状のリスクを抱える患者に信頼性の高い治療選択肢を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の手術後の吐き気と嘔吐 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の手術後の吐き気と嘔吐市場：成長率分析
• 世界の手術後の吐き気と嘔吐市場の実績：規模と成長, 2019-2024
• 世界の手術後の吐き気と嘔吐市場の予測：規模と成長, 2024-2029, 2034F
• 世界の手術後の吐き気と嘔吐総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の手術後の吐き気と嘔吐市場：治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• セロトニン拮抗薬
• ステロイド
• ドーパミン拮抗薬
• ニューロキニンNK-1受容体拮抗薬
• 非薬物治療
• その他の治療の種類
• 世界の手術後の吐き気と嘔吐市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 静脈内
• 経皮
• その他の投与経路
• 世界の手術後の吐き気と嘔吐市場：患者の人口統計別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児患者
• 成人患者
• 高齢患者
• 世界の手術後の吐き気と嘔吐市場：手術の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 整形外科
• 婦人科手術
• 一般外科
• 心臓手術
• 眼科手術
• 世界の手術後の吐き気と嘔吐市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 専門クリニック
• その他のエンドユーザー
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、セロトニン拮抗薬、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンダンセトロン
• グラニセトロン
• パロノセトロン
• ドラセトロン
• トロピセトロン
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、ステロイド、実績と予測, 2019-2024, 2024-2029F, 2034F
• デキサメタゾン
• メチルプレドニゾロン
• ヒドロコルチゾン
• プレドニゾロン
• ベタメタゾン
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、ドーパミン拮抗薬、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトクロプラミド
• ドロペリドール
• プロクロルペラジン
• ドンペリドン
• クロルプロマジン
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、ニューロキニンNK-1受容体拮抗薬、実績と予測, 2019-2024, 2024-2029F, 2034F
• アプレピタント
• フォサプレピタント
• ロラピタント
• ネットピタント
• カソピタント
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、非薬物治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• 指圧
• アロマセラピー
• 催眠療法
• 電気鍼療法
• ショウガサプリメント
• 世界の手術後の吐き気と嘔吐市場：タイプ別サブセグメンテーション、その他の治療の種類、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 抗コリン薬
• カンナビノイド
• 併用療法
• ハーブと自然療法

第7章 地域別・国別分析

• 世界の手術後の吐き気と嘔吐市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の手術後の吐き気と嘔吐市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 手術後の吐き気と嘔吐市場：競合情勢
• 手術後の吐き気と嘔吐市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter Corporation
• Teva Pharmaceutical Industries Ltd.
• Sandoz Group AG
• Daiichi Sankyo Inc.
• Fresenius Kabi AG
• Eisai Co. Ltd.
• Dr. Reddy's Laboratories
• Kyowa Hakko Kirin Taiwan Co. Ltd.
• Cipla Ltd.
• Alkem Laboratories Ltd.
• Eagle Pharmaceuticals Inc.
• Camurus AB
• Helsinn Healthcare SA
• Heron Therapeutics Inc.
• Advacare Pharma

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 手術後の吐き気と嘔吐市場2029：新たな機会を提供する国
• 手術後の吐き気と嘔吐市場2029：新たな機会を提供するセグメント
• 手術後の吐き気と嘔吐市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Post-operative nausea and vomiting (PONV) is a common complication that typically occurs within 24 to 48 hours after surgery, often triggered by anesthesia, pain medications, or the body's response to surgical stress. This condition can significantly hinder a patient's recovery, leading to discomfort, delayed healing, and an increased risk of complications such as dehydration or electrolyte imbalances.

The main treatments for post-operative nausea and vomiting include serotonin antagonists, steroids, dopamine antagonists, neurokinin NK-1 receptor antagonists, non-pharmacological treatments, and others. Serotonin antagonists are medications that block serotonin receptors, preventing nausea and vomiting signals from reaching the brain. The various routes of administration include oral, intravenous, transdermal, and others, catering to different patient demographics such as pediatric, adult, and geriatric patients. Surgical procedures where PONV treatments are commonly used include orthopedic, gynecological, general, cardiac, and ophthalmic surgeries. These treatments are utilized by a range of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and others.

The post-operative nausea and vomiting market research report is one of a series of new reports from The Business Research Company that provides post-operative nausea and vomiting market statistics, including post-operative nausea and vomiting industry global market size, regional shares, competitors with a post-operative nausea and vomiting market share, detailed post-operative nausea and vomiting market segments, market trends and opportunities, and any further data you may need to thrive in the post-operative nausea and vomiting industry. This post-operative nausea and vomiting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The post-operative nausea and vomiting market size has grown strongly in recent years. It will grow from $2.11 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to increased research and development activities, a rising demand for advanced therapies, higher healthcare expenditures, a growing focus on personalized medicine, and the expanding adoption of digital health technologies.

The post-operative nausea and vomiting market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The projected growth during the forecast period can be attributed to the increasing demand for pharmaceuticals, the rise of combination therapy, growing awareness and healthcare investments, a rising geriatric population, and the increasing number of cancer cases. Key trends expected during this period include advancements in antiemetic therapies, strategic collaborations, innovative drug formulations, the integration of advanced diagnostic tools, and the development of electronic simulation devices.

The increasing number of surgical procedures is expected to drive the growth of the post-operative nausea and vomiting market. Surgical procedures involve medical interventions that utilize tools to diagnose, treat, or remove damaged tissues, organs, or abnormalities through cutting or manipulation. The rise in surgical procedures is attributed to advancements in medical technology, which have made surgeries safer, more effective, and minimally invasive, leading to greater patient acceptance and broader applicability. Effective management of post-operative nausea and vomiting enhances surgical procedures by improving patient comfort, reducing recovery time, minimizing complications, and ensuring smoother post-operative care, ultimately leading to better surgical outcomes. For example, in November 2024, the Australian Institute of Health and Welfare reported that during the 2023-24 period, 771,600 patients were admitted for surgery from public hospital elective surgery waiting lists, reflecting a 4.9% increase compared to 2022-23. This trend highlights the growing number of surgical procedures, which is fueling the expansion of the post-operative nausea and vomiting market.

Companies in the post-operative nausea and vomiting market are focusing on developing critical injectable medications using advanced emulsion formulations and sustained-release technology to improve treatment efficacy and provide prolonged symptom relief for surgical patients. These critical injectable medications are essential drugs administered via injection to deliver immediate and effective treatment for serious or urgent medical conditions. For example, in July 2024, Avenacy, a US-based specialty pharmaceutical company, introduced Palonosetron Hydrochloride Injection in 0.25 mg/5 mL single-dose vials. This formulation helps healthcare providers reduce dosing errors and improve patient safety. The injection is designed to prevent nausea and vomiting induced by chemotherapy and to manage post-operative nausea and vomiting for up to 24 hours following surgery, offering a reliable treatment option for patients at risk of these conditions.

In June 2022, Eagle Pharmaceuticals, Inc., a US-based pharmaceutical company, acquired Acacia Pharma Group plc for an undisclosed amount. This acquisition aims to strengthen Eagle Pharmaceuticals' acute care portfolio and enhance hospital sales capabilities by leveraging its network to promote BARHEMSYS for post-operative nausea and vomiting rescue treatment and BYFAVO for procedural sedation. The deal addresses significant unmet clinical needs and aims to improve patient care. Acacia Pharma Group plc, a UK-based hospital pharmaceutical company, specializes in supportive care treatments for post-operative nausea and vomiting.

Major players in the post-operative nausea and vomiting market are Pfizer Inc., Merck KGaA, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited., Baxter Corporation, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Inc., Fresenius Kabi AG, Eisai Co. Ltd., Dr. Reddy's Laboratories, Kyowa Hakko Kirin Taiwan Co. Ltd., Cipla Ltd., Alkem Laboratories Ltd., Eagle Pharmaceuticals Inc., Camurus AB, Helsinn Healthcare SA, Heron Therapeutics Inc., Advacare Pharma.

North America was the largest region in the post-operative nausea and vomiting market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in post-operative nausea and vomiting report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the post-operative nausea and vomiting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-operative nausea and vomiting market consists of revenues earned by entities by providing services such as patient monitoring, anesthesia management, antiemetic drug administration, postoperative care, and clinical counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The post-operative nausea and vomiting market also includes sales of antiemetic drugs, intravenous fluids, nausea relief patches, oxygen therapy devices, and acupuncture kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Post-Operative Nausea And Vomiting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-operative nausea and vomiting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for post-operative nausea and vomiting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The post-operative nausea and vomiting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Serotonin Antagonists; Steroids; Dopamine Antagonists; Neurokinin NK-1 Receptor Antagonists; Non-pharmacological Treatment; Other Treatment Types
• 2) By Route Of Administration: Oral; Intravenous; Transdermal; Other Route Of Administrations
• 3) By Patient Demographics: Pediatric Patients; Adult Patients; Geriatric Patients
• 4) By Surgical Procedure Type: Orthopedic Surgery; Gynecological Surgery; General Surgery; Cardiac Surgery; Ophthalmic Surgery
• 5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
• Sub Segments:
• 1) By Serotonin Antagonists Type: Ondansetron; Granisetron; Palonosetron; Dolasetron; Tropisetron
• 2) By Steroids Type: Dexamethasone; Methylprednisolone; Hydrocortisone; Prednisolone; Betamethasone
• 3) By Dopamine Antagonists Type: Metoclopramide; Droperidol; Prochlorperazine; Domperidone; Chlorpromazine
• 4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant; Fosaprepitant; Rolapitant; Netupitant; Casopitant
• 5) By Non-Pharmacological Treatment Type: Acupressure; Aromatherapy; Hypnotherapy; Electroacupuncture; Ginger Supplements
• 6) By Other Treatment Types: Antihistamines; Anticholinergics; Cannabinoids; Combination Therapy; Herbal & Natural Remedies
• Companies Mentioned: Pfizer Inc.; Merck KGaA; Novartis AG; GlaxoSmithKline Plc; Takeda Pharmaceutical Company Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Post-Operative Nausea And Vomiting Market Characteristics

3. Post-Operative Nausea And Vomiting Market Trends And Strategies

4. Post-Operative Nausea And Vomiting Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Post-Operative Nausea And Vomiting Growth Analysis And Strategic Analysis Framework

• 5.1. Global Post-Operative Nausea And Vomiting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Post-Operative Nausea And Vomiting Market Growth Rate Analysis
• 5.4. Global Post-Operative Nausea And Vomiting Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Post-Operative Nausea And Vomiting Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Post-Operative Nausea And Vomiting Total Addressable Market (TAM)

6. Post-Operative Nausea And Vomiting Market Segmentation

• 6.1. Global Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serotonin Antagonists
• Steroids
• Dopamine Antagonists
• Neurokinin NK-1 Receptor Antagonists
• Non-pharmacological Treatment
• Other Treatment Types
• 6.2. Global Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Transdermal
• Other Route Of Administrations
• 6.3. Global Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Patients
• Adult Patients
• Geriatric Patients
• 6.4. Global Post-Operative Nausea And Vomiting Market, Segmentation By Surgical Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedic Surgery
• Gynecological Surgery
• General Surgery
• Cardiac Surgery
• Ophthalmic Surgery
• 6.5. Global Post-Operative Nausea And Vomiting Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Other End-Users
• 6.6. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Serotonin Antagonists Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ondansetron
• Granisetron
• Palonosetron
• Dolasetron
• Tropisetron
• 6.7. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Steroids Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dexamethasone
• Methylprednisolone
• Hydrocortisone
• Prednisolone
• Betamethasone
• 6.8. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Dopamine Antagonists Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metoclopramide
• Droperidol
• Prochlorperazine
• Domperidone
• Chlorpromazine
• 6.9. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Neurokinin NK-1 Receptor Antagonists Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aprepitant
• Fosaprepitant
• Rolapitant
• Netupitant
• Casopitant
• 6.10. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Non-Pharmacological Treatment Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acupressure
• Aromatherapy
• Hypnotherapy
• Electroacupuncture
• Ginger Supplements
• 6.11. Global Post-Operative Nausea And Vomiting Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Anticholinergics
• Cannabinoids
• Combination Therapy
• Herbal & Natural Remedies

7. Post-Operative Nausea And Vomiting Market Regional And Country Analysis

• 7.1. Global Post-Operative Nausea And Vomiting Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Post-Operative Nausea And Vomiting Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Post-Operative Nausea And Vomiting Market

• 8.1. Asia-Pacific Post-Operative Nausea And Vomiting Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Post-Operative Nausea And Vomiting Market

• 9.1. China Post-Operative Nausea And Vomiting Market Overview
• 9.2. China Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Post-Operative Nausea And Vomiting Market

• 10.1. India Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Post-Operative Nausea And Vomiting Market

• 11.1. Japan Post-Operative Nausea And Vomiting Market Overview
• 11.2. Japan Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Post-Operative Nausea And Vomiting Market

• 12.1. Australia Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Post-Operative Nausea And Vomiting Market

• 13.1. Indonesia Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Post-Operative Nausea And Vomiting Market

• 14.1. South Korea Post-Operative Nausea And Vomiting Market Overview
• 14.2. South Korea Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Post-Operative Nausea And Vomiting Market

• 15.1. Western Europe Post-Operative Nausea And Vomiting Market Overview
• 15.2. Western Europe Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Post-Operative Nausea And Vomiting Market

• 16.1. UK Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Post-Operative Nausea And Vomiting Market

• 17.1. Germany Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Post-Operative Nausea And Vomiting Market

• 18.1. France Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Post-Operative Nausea And Vomiting Market

• 19.1. Italy Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Post-Operative Nausea And Vomiting Market

• 20.1. Spain Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Post-Operative Nausea And Vomiting Market

• 21.1. Eastern Europe Post-Operative Nausea And Vomiting Market Overview
• 21.2. Eastern Europe Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Post-Operative Nausea And Vomiting Market

• 22.1. Russia Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Post-Operative Nausea And Vomiting Market

• 23.1. North America Post-Operative Nausea And Vomiting Market Overview
• 23.2. North America Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Post-Operative Nausea And Vomiting Market

• 24.1. USA Post-Operative Nausea And Vomiting Market Overview
• 24.2. USA Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Post-Operative Nausea And Vomiting Market

• 25.1. Canada Post-Operative Nausea And Vomiting Market Overview
• 25.2. Canada Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Post-Operative Nausea And Vomiting Market

• 26.1. South America Post-Operative Nausea And Vomiting Market Overview
• 26.2. South America Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Post-Operative Nausea And Vomiting Market

• 27.1. Brazil Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Post-Operative Nausea And Vomiting Market

• 28.1. Middle East Post-Operative Nausea And Vomiting Market Overview
• 28.2. Middle East Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Post-Operative Nausea And Vomiting Market

• 29.1. Africa Post-Operative Nausea And Vomiting Market Overview
• 29.2. Africa Post-Operative Nausea And Vomiting Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Post-Operative Nausea And Vomiting Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Post-Operative Nausea And Vomiting Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Post-Operative Nausea And Vomiting Market Competitive Landscape And Company Profiles

• 30.1. Post-Operative Nausea And Vomiting Market Competitive Landscape
• 30.2. Post-Operative Nausea And Vomiting Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis

31. Post-Operative Nausea And Vomiting Market Other Major And Innovative Companies

• 31.1. Baxter Corporation
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Sandoz Group AG
• 31.4. Daiichi Sankyo Inc.
• 31.5. Fresenius Kabi AG
• 31.6. Eisai Co. Ltd.
• 31.7. Dr. Reddy's Laboratories
• 31.8. Kyowa Hakko Kirin Taiwan Co. Ltd.
• 31.9. Cipla Ltd.
• 31.10. Alkem Laboratories Ltd.
• 31.11. Eagle Pharmaceuticals Inc.
• 31.12. Camurus AB
• 31.13. Helsinn Healthcare SA
• 31.14. Heron Therapeutics Inc.
• 31.15. Advacare Pharma

32. Global Post-Operative Nausea And Vomiting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Operative Nausea And Vomiting Market

34. Recent Developments In The Post-Operative Nausea And Vomiting Market

35. Post-Operative Nausea And Vomiting Market High Potential Countries, Segments and Strategies

• 35.1 Post-Operative Nausea And Vomiting Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Post-Operative Nausea And Vomiting Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Post-Operative Nausea And Vomiting Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer